site stats

Crispr therapeutics insider trading

WebInsider trading activities (stock purchases, sales, and option exercises) reported by insiders of Crispr Therapeutics Ag (CRSP) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Crispr Therapeutics Ag. Table 2 shows the detailed insider transactions. This company's CIK number is 1674416. WebInsider trades for Crispr Therapeutics AG (CRSP). Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Real-time Insider Trading Stock Screener. Long …

CRISPR Therapeutics AG Common Shares (CRSP) - Nasdaq

WebJun 6, 2024 · The foundational CRISPR / Cas9 patent estate for human therapeutic use was licensed from the company's scientific founder Emmanuelle Charpentier, Ph.D. CRISPR Therapeutics AG is headquartered in ... WebApr 13, 2024 · CRSP has an average price target of $84.19 among all 26 analysts with coverage of the stock. That implies an upside of about 68%. However, insider activity over the past three years paints a ... scsba youtube https://wilhelmpersonnel.com

Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?

WebApr 12, 2024 · Kistler Tiffany Companies LLC grew its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP - Get Rating) by 439.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission.The firm owned 4,217 shares of the company's stock after acquiring an additional 3,435 shares … Web2 days ago · Complete CRISPR Therapeutics AG stock information by Barron's. View real-time CRSP stock price and news, along with industry-best analysis. Web18 hours ago · InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Against the backdrop of a solid day on Wall Street, CRISPR Therapeutics (NASDAQ:CRSP) … scsb class

CRISPR Therapeutics AG (CRSP) Soars 16.3%: Is Further Upside Left …

Category:Why CRISPR Therapeutics (CRSP) Shares Are Trading Higher Today …

Tags:Crispr therapeutics insider trading

Crispr therapeutics insider trading

Lawrence Klein Net Worth, Biography, and Insider Trading

WebApr 3, 2024 · CRISPR Therapeutics and Vertex Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell … WebFind the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing.

Crispr therapeutics insider trading

Did you know?

Web1 day ago · CRISPR Therapeutics AG (CRSP) closed the last trading session at $45.41, gaining 0.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ... WebJul 27, 2024 · The average CRISPR Therapeutics AG price target is $98.94, implying 25.4% upside potential. Technical Analysis: CRISPR Therapeutics’ Share Price Could Fall. CRISPR Therapeutics AG shares are currently trading at $78.93. The stock price looks appealing as it is about 15% below the midpoint of its 52-week range of $42.51 to $142.64.

WebFeb 27, 2024 · The estimated net worth of Lawrence Otto Klein is at least $1.42 million as of January 15th, 2024. Dr. Klein owns 28,666 shares of CRISPR Therapeutics stock worth …

WebApr 13, 2024 · Investment analysts at Cantor Fitzgerald started coverage on shares of CRISPR Therapeutics (NASDAQ:CRSP – Get Rating) in a research note issued to … WebApr 14, 2024 · CRISPR Therapeutics AG CRSP shares soared 16.3% in the last trading session to close at $50.56. The move was backed by solid volume with far more shares …

WebApr 4, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRSP shares currently have a short interest ratio of 10.0. Learn More on CRISPR Therapeutics's short interest ratio.

Web16 hours ago · CRISPR Therapeutics AG (NASDAQ:CRSP) is something of a hot-button topic by virtue of its very existence.But one analyst, in particular, is less interested in the controversy than in the potential involved in this biotech stock.The resulting fresh coverage with a positive rating helped send CRISPR up over 16% in Thursday afternoon’s trading. scsb btocWebFind real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business. scsb eatmWebMar 29, 2024 · Learn More about insider trades at CRISPR Therapeutics. ... Samarth Kulkarni Insider Trading History at CRISPR Therapeutics. Transaction Date Buy/Sell … scsb.com.twWebCRISPR Therapeutics Insider Trading History Chart. This chart shows the insider buying and ... pc show all windowsWebApr 6, 2024 · The main competitors of CRISPR Therapeutics include Denali Therapeutics (DNLI), Vir Biotechnology (VIR), Vaxcyte (PCVX), Abcam (ABCM), Ginkgo Bioworks (DNA), Immunocore (IMCR), Beam Therapeutics (BEAM), Relay Therapeutics (RLAY), Krystal Biotech (KRYS), and Halozyme Therapeutics (HALO). These companies are all part of … scsb bank codeWeb18 hours ago · InvestorPlace - Stock Market News, Stock Advice & Trading Tips. Against the backdrop of a solid day on Wall Street, CRISPR Therapeutics (NASDAQ:CRSP) distinguished itself, popping up nearly 16% ... scs becksWebCRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR ... scs baxter sofa